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ABSTRACT The pH-dependent insertion of pHLIP across membranes is proving to be a useful property for targeting acidic
tissues or tumors and delivering drugs attached to its C-terminus. It also serves as a model peptide for studies of protein insertion
into membranes, so further elucidation of the insertion mechanism of pHLIP and its features is desirable. We examine how
the peptide perturbs a model phosphatidylcholine membrane and how it associates with the lipid bilayer using an array of
ﬂuorescence techniques, including ﬂuorescence anisotropy measurements of TMA-DPH anchored in bilayers, quenching of
pHLIP ﬂuorescence by brominated lipids and acrylamide, and measurements of energy transfer between aromatic residues
of pHLIP and TMA-DPH. When pHLIP is bound to the surface of bilayers near neutral pH, the membrane integrity is preserved
whereas the elastic properties of bilayers are changed as reported by an increase of membrane viscosity. When it is inserted,
there is little perturbation of the lipids. The results also suggest that pHLIP can bind to themembrane surface in a shallow or a deep
mode depending on the phase state of the lipids. Using parallax analysis, the change of the penetration depth of pHLIP was
estimated to be 0.4 A˚ from the bilayer center and 2.8 A˚ from the membrane surface after the liquid-to-gel phase transition.
INTRODUCTION
The isolated C-helix of bacteriorhodopsin has been observed
previously to be water-soluble, to bind to lipid bilayer surfaces
as an unstructured peptide above pH 7, and to spontaneously
insert as an a-helix across lipid bilayers in a pH-dependent
manner, with a pKapp of 6 (1). The insertion of this peptide,
dubbed pHLIP, for pH low insertion peptide, is reversible
and oriented such as the C-terminus is translocated across
the membrane whereas the N-terminus stays outside of
the membrane (2,3). The insertion mechanism is coupled to
the protonation of one or both of two aspartic acid residues
located in the transmembrane part of the peptide (Asps at
positions 85 and 96 in the bacteriorhodopsin sequence) (1,4).
The thermodynamics of pHLIP binding and insertion in
membranes has been analyzed in detail (1,5), and its three
major forms (soluble in aqueous solution, bound at the
membrane surface, and inserted across a lipid bilayer) were
found to be monomeric at peptide concentrations less than
;7 mM (3).
Owing to its exceptional characteristics, pHLIP can be
used as a model peptide for studying membrane protein
folding and insertion in lipid bilayers, or as a tool for thera-
peutic drug delivery. Individual peptides that mimic trans-
membrane sections of membrane proteins are suitable model
systems for biophysical studies to obtain an insight into the
molecular interactions that play a role in the native system
(6–8). Such an approach is rationalized by the two-stage
process model of membrane protein folding, when individual
helices first insert and, then, oligomerize to form higher order
structures (9,10). Folding pathways for membrane proteins
can be based on this model even if additional steps are often
required for achieving the final equilibration of native and
functional structures in vivo (11). Studying a single helix
may thus provide an insight into the folding of more complex
membrane proteins (12,13).
Biological membranes are the main barriers for thera-
peutic drug delivery. The energy released as a result of
pHLIP insertion into a membrane can be used to move cell-
impermeable cargo molecules across a membrane into a cell
(2). The ability of pHLIP to target cells in an extracellular
acidic environment, which is associated with tumors and
other pathological conditions, has been confirmed in vivo by
whole-body fluorescence and positron emission tomography
imaging (4,14). pHLIP has also been shown to induce shape
changes of RBCs at neutral pH, consistent with the idea that
peptide binding perturbs the bilayer structure, whereas at low
pH, i.e., when the peptide is inserted in lipid bilayers, the
perturbations are absent (4).
The objective of this study is to gain further insights into
the interaction of pHLIP with a lipid bilayer both for fun-
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damental understanding and to facilitate the rational design
of sequences that insert into cell membranes in a controlled
way. The strain that pHLIP induces in a bilayer when it is
bound to its surface, the positioning of the peptide at the
bilayer surface in the liquid-crystal and gel phases, and the
changes on membrane insertion were investigated in detail by
a variety of biophysical methods.
MATERIALS AND METHODS
Materials
Mops was purchased from Roche Diagnostics (Indianapolis, IN). Urea,
melittin peptide from honey bee venom, and Triton X-100 were supplied by
Sigma-Aldrich (St. Louis, MO). One M TrisHCl pH 8 solution was from
American Bioanalytical (Natick, MA). The pH of the samples was checked
using a MI-415 pH combination electrode supplied by Microelectrodes
(Bedford, MA). POPC, DMPC, DPPC, (6-7)Br2-PC, and (9-10)Br2-PC in
chloroform, and a mini-extruder were purchased from Avanti Polar Lipids
(Alabaster, AL). TMA-DPH and calcein were from Invitrogen Molecular
Probes (Carlsbad, CA). The HiPrep 26/10 Desalting column and the A¨kta
FPLC system were from GE Healthcare Life Sciences (Piscataway, NJ).
Slide-A-lyser dialysis cassettes of 3,500 Da cutoff (0.5 to 3 mL capacity)
were from Pierce Biotechnology (Rockford, IL). pHLIP with the following
sequence GGEQNPIYWARYADWLFTTPLLLLDLALLVDADEGT and the
variant with the six last residues in C-terminus, –NANQGT were chemically
synthesized and purified (.95%) by Biopeptide (San Diego, CA).
Preparation of pHLIP sample
A lyophilized powder of the peptide was dissolved at 1 mg mL1 in 8 M urea,
20 mM TrisHCl, 50 mM NaCl, pH 8. After vortexing, the sample was dialyzed
four times against 500 mL of the same buffer without urea. The buffer was
exchanged for 20 mM Mops, 50 mM NaCl, pH 7.9 over four additional dialysis
baths. The final concentration of pHLIP was determined by UV absorption
using a molar extinction coefficient of e280 ¼ 13,940 M1 cm1 (2).
Preparation of vesicle suspensions
Five milligrams of lipids in chloroform (the initial concentrations were 25 mg
mL1 for POPC and 10 mg mL1 for DMPC) were dried in a rotary evap-
orator and then held under vacuum overnight. The dried lipid film was re-
hydrated with 1 mL of water and vortexed. The resulting vesicles were
subjected to five cycles of freeze-thawing to produce liposomes, which then
were extruded (25 times using a mini-extruder) through 100 nm pore di-
ameter filters to obtain LUVs. Lipid concentration was checked using
Marshall’s assay (15).
Steady-state anisotropy measurements
LUVs were prepared from DMPC according to the protocol described above
and TMA-DPH in methanol was added from a 5 mM stock solution to give a
final probe/lipid molar ratio of 1:500 (0.2 mol %). To allow the probe to be
incorporated, liposomes were incubated at 30C (i.e., above Tm) for at
least 1 h before use. Increasing concentrations of pHLIP peptide (0.2, 0.4,
1.0, and 2.0 mol %) were mixed with 1.9 mM LUVs and samples were
allowed to equilibrate for 15 min at 30C before the measurements. The
buffers were 20 mM Mops at pH 7.5 or pH 4.0. All measurements were taken
in 3 mm wide cuvettes (sample volume ¼ 150 mL). Fluorescence polariza-
tion was measured on a PTI fluorimeter equipped with a Peltier device
connected to a temperature controller. The widths of excitation and emission
slits were 4 nm. The excitation and emission wavelengths were 350 nm and
420 nm, respectively. Measurements were started at 10C and the tem-
perature was increased gradually to 40C with steps of 2C. An equilibration
time of 2 min was allowed after each temperature change. For each tem-
perature, the emission fluorescence was recorded for 1 min and averaged.
The vertically and horizontally polarized emission intensities were corrected
for background scattering by subtraction of the corresponding polarized
intensities of a blank containing an unlabeled LUV suspension. Steady-
state fluorescence anisotropy was determined according to the following
equation (16):
r ¼ IVV  GIVH
IVV1 2GIVH
; (1)
where IVV and IVH are the emission intensities measured with the excitation
polarizer set in the vertical direction and the emission polarizer oriented in the
vertically or horizontally direction, respectively. The instrumental factor G
(G ¼ IHV/IHH) was determined by measuring the emission intensities of the
fluorescent probe with the excitation polarizer oriented in the horizontally
direction.
FRET measurements
Measurements were carried out using a SLM-Aminco 8000C spectro-
fluorimeter (ISS, Champaign, IL) equipped with a thermo-bath RTE-111
(Neslab). The widths of the excitation and emission slits were 4 nm. Energy
transfer between aromatic residues of pHLIP excited at 280 nm and TMA-
DPH (0.2 mol %) incorporated in DMPC or POPC bilayers was recorded
over the wavelength range from 290 to 540 nm as a function of temperature.
Measurements were started at 35C and the temperature was lowered to 15C
in steps of 5C. The molar ratio of pHLIP to lipids was 0.25 mol % and the
concentration of lipids was 0.85 mM. The buffers used in the experiments
were 20 mM Mops at pH 7.5 or pH 4.3. Light scattering and fluorescence
backgrounds of a blank containing TMA-DPH inserted into LUVs were
subtracted from the spectra.
CD spectroscopy
Measurements were carried out using a CD spectrometer model 215 (Aviv,
Lakewood, NJ). All spectra were recorded over the wavelength range from
200 to 280 nm with a 1 nm wavelength step and 3.0 s averaging time.
Samples were measured in a 1.0 cm path length cuvette, with a sample
volume of 3 mL, at 37C. Peptide concentrations were checked at the end of
each assay by quantitative amino acid analysis and these values were used to
normalize the mean residue ellipticity. Two scans were averaged for each
sample and the appropriate background contribution, i.e., buffer with or
without LUVs, was subtracted from the spectra.
Calcein leakage experiments
The dried POPC lipid film was rehydrated with 50 mM calcein in 10 mM
Mops, 150 mM NaCl, 5 mM EDTA, pH 7.4. LUVs were prepared using the
standard procedure and the free dye was removed by passage over a HiPrep
26/10 Desalting column (Sephadex G-25 Fine) pre-equilibrated with the
same buffer. The total lipid concentration was adjusted with buffer to a final
concentration of 0.1 mM. The LUV sample was kept at 4C for a maximum
of 3 days. Calcein leakage from the vesicles was monitored by measuring the
decrease of self-quenching (excitation and emission wavelengths were set at
450 nm and 515 nm, respectively). The widths of excitation and emission
slits were 2 nm. The percentage of dye released from the vesicles was cal-
culated using the equation (17):
%release ¼ 1003 ðIF  IBÞ=ðIT  IBÞ; (2)
where IB is the background (self-quenched) intensity of calcein encapsulated
in vesicles, IF is the enhanced fluorescence intensity resulting from the
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dilution of dye in the medium, IT is the total fluorescence intensity after
complete permeabilization by addition of 0.05% Triton X-100 from a 20%
stock solution.
Quenching of pHLIP intrinsic ﬂuorescence
by acrylamide
Experiments were carried out by measuring the fluorescence intensity of
pHLIP in separate samples containing increasing concentrations of acryl-
amide taken from a 2 M stock solution. Measurements were taken at pH 7.5
or pH 4.5 in the presence of DMPC LUVs at 35C and 15C, or in the
presence of DPPC LUVs at 35C. The excitation wavelength was 280 nm
and emission spectra were recorded between 290 and 420 nm. The inner filter
effect was corrected using the following equation (16):
Fcorr ¼ Fobs3 10ðAex1AemÞ=2; (3)
where Fcorr and Fobs are the corrected and observed fluorescence intensities,
respectively. Aex and Aem are the measured absorbance at the excitation and
emission wavelengths, respectively. Quenching data were analyzed by a fit to
the Stern-Volmer equation (16):
F0=F ¼ 11KSV½Q; (4)
where F0 and F are the fluorescence intensities in the absence and in the
presence of the quencher, respectively, [Q] is the molar quencher concen-
tration (in M) and KSV is the Stern-Volmer quenching constant (in M
1).
Depth measurements by bromine quenching of
pHLIP intrinsic ﬂuorescence
Collisional quenching of tryptophan fluorescence by brominated phospho-
lipids (Br2-PCs) was used to assess the depth of insertion of these residues in
the lipid bilayer. Br2-PCs are considered to be appropriate for this purpose
because they are thought to minimally perturb the membrane. Bromine
quenching of pHLIP was analyzed as a function of temperature. After mixing
0.25 mol % pHLIP with 0.6 mM DMPC LUVs with or without 30 mol %
(6,7)Br2-PC incorporated in the bilayer, fluorescence emission spectra were
recorded on excitation at 280 nm, at pH 7.5 or pH 4.5, and at temperatures
above (35C) and below (15C) Tm. The difference of pHLIP quenching
between the two conditions indicates a difference in depth of penetration of
pHLIP adsorbed at the bilayer surface. Accordingly, the depth of the tryp-
tophan residues was calculated by the parallax method using an additional
sample of 0.25 mol % pHLIP mixed with 0.6 mM DMPC LUVs containing
30 mol % (9,10)Br2-PC. The differences in quenching of pHLIP fluores-
cence by (6,7)- and (9,10)Br2-PC incorporated separately in DMPC LUVs
allow the calculation of the probability for the localization of tryptophan
residues in the bilayer using the following equation (18):
zcF ¼ Lc11 f½ð1=pCÞlnðF1=F2Þ  L221=2L21g; (5)
where zcF is the depth of the fluorophore as measured from the center of the
bilayer, Lc1 is the distance of the center of the bilayer from the shallow quencher,
L21 is the difference in depth between the two quenchers, F1 is the fluorescence
intensity in the presence of the shallow quencher,F2 is the fluorescence intensity
in the presence of the deep quencher, and C is the two-dimensional quencher
concentration in the plane of the membrane (molecules/A˚2).
RESULTS
Membrane permeability
Our previous data indicated that pHLIP induces membrane
distortion of human RBCs at neutral pH, but no leakage of
hemoglobin was observed (4), nor was there disruption of
vesicles encapsulating ANTS or DPX (3). To confirm that
pHLIP does not induce gross membrane leakage over a wide
rang of peptide concentrations, the inability of pHLIP to
cause the release of entrapped vesicle contents was checked
at room temperature by monitoring the fluorescence intensity
of calcein encapsulated in POPC liposomes at high self-
quenching concentrations (Fig. 1). The appearance of fluo-
rescence is a sensitive measure of vesicle permeability. As a
positive control, the experiment was also carried out using a
lytic peptide (melittin, from honey bee venom), which can
form pores in cell membranes (19). The comparison between
melittin and pHLIP confirms that membrane integrity is
preserved at low concentrations of pHLIP.
FIGURE 1 Effect of pHLIP versus melittin on the membrane leakage. (A)
Kinetics of calcein leakage. The release of calcein (50 mM) encapsulated in
POPC vesicles was monitored by the increase in fluorescence intensity at
515 nm (excitation at 450 nm), on addition of 0.2 mol % melittin or pHLIP
(arrow 1). Complete leakage was achieved on addition of 0.05% Triton
X-100 (arrow 2). The percentage of calcein release was calculated as described
in Materials and Methods. The total lipid concentration was 0.1 mM and
the buffer was 10 mM Mops, 150 mM NaCl, 5 mM EDTA, at pH 7.4. (B)
Calcein release versus peptide concentrations. The intensity was recorded
after 30 min incubation in the dark at room temperature.
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Membrane ﬂuidity
To study the effects of pHLIP on membrane fluidity, we
measured changes in fluorescence anisotropy of a fluorescent
probe (TMA-DPH) incorporated in DMPC bilayers versus
temperature (Fig. 2). Fluorescence anisotropy reports the
degree of rotational mobility of a fluorescent molecule and,
therefore, it highly depends on the viscosity of the medium in
which the fluorophore is dissolved. Anisotropy values can be
used to probe the microviscosity of lipid membranes into
which the fluorophore partitions (see (20) for review). TMA-
DPH is a hydrophobic molecule, which is anchored at the
water/lipid interface due to its charged trimethylammonium
group. This fluorophore reports then on the mobility of the
lipid headgroup region of membranes (21,22). Below Tm
(23C), DMPC lipids are in a gel phase, which is charac-
terized by a low fluidity and slow lateral and rotational dif-
fusions, whereas above this temperature, they are in the
liquid-crystal state, which is characterized by a high fluidity
and a fast diffusion (see (23) for review). Changes in anisot-
ropy values of TMA-DPH from 0.18 to 0.31 with a decrease of
temperature follow the phase transition of DMPC lipids. In
the presence of low concentration of pHLIP at pH 7.5, there
are no significant changes in the anisotropy. However, at high
peptide concentration (2.0 mol % pHLIP or low lipid/peptide
ratio of 50:1) the anisotropy values increase ;10%, espe-
cially at low temperatures. This effect is a consequence of
pHLIP interaction with the outer leaflet of bilayers, consistent
with the induction of membrane perturbations, and it is en-
hanced by increasing peptide concentration. Interestingly,
surface binding of pHLIP increases the value of Tm by;2C
for DMPC. The increase in anisotropy at low temperatures
cannot be associated with better binding of pHLIP to the lipid
bilayer, because thermodynamics data show clearly that the
adsorption constant of pHLIP by POPC vesicles is 2 times
lower at 15C than at 35C (5). At pH 4.0, i.e., when the
peptide is inserted across the membrane, almost no difference
is observed with regard to the membrane viscosity, even in
the presence of 2.0 mol % pHLIP. Identical results were
obtained with the fluorescent probe DPH, which reports on
the order of hydrophobic chains in the core region of bilayers.
Depth of penetration of pHLIP adsorbed at the
bilayer surface
The penetration depth of surface-bound pHLIP into bilayers
in the liquid-crystal and gel phases was estimated by analysis
of quenching of pHLIP emission by brominated lipids (Br2-
PCs) versus temperature. In Fig. 3, fluorescence spectra are
reported for pHLIP, at pH 7.5 or 4.5, in the presence of
DMPC LUVs with and without Br2-PCs. Comparison of
fluorescence quenching of membrane surface-bound pHLIP
at 35C and 15C, i.e., at temperatures above and below Tm
respectively (Fig. 3, A and B), shows a less significant
quenching at high temperature than at low temperature. The
quenching efficiency of pHLIP by Br2-PC is ;10% at 35C
and ;20% at 15C. At pH 4.5 (Fig. 3, C and D), the
quenching efficiency is insignificantly affected by the phase
transition (;53% at 35C and ;54% at 15C). The position
of maximum of pHLIP emission shifts toward long and short
wavelengths as a result of quenching by Br2-PCs at neutral
and low pHs, respectively. Because tryptophan residues
contribute much more to emission fluorescence than tyrosine
and phenylalanine residues on excitation at 280 nm, we can
attribute the fluorescence of pHLIP to tryptophan residues.
Therefore, the observed shift suggests heterogeneity of
tryptophan residue locations in the lipid bilayer in both states,
which correlates well with our previous fluorescence de-
composition analysis that showed two populations of tryp-
FIGURE 2 Effect of pHLIP on lipid membrane fluidity. The fluorescence
anisotropy of TMA-DPH incorporated in DMPC bilayers was monitored in
the presence of pHLIP at pH 7.5 (A) or pH 4.0 (B). Several concentrations of
pHLIP (0.2, 0.4, 1.0, and 2.0 mol %) were tested with 1.9 mM DMPC LUVs
containing 0.2 mol % TMA-DPH. The samples were excited by polarized
light at 350 nm and emission was monitored at 420 nm. The fluorescence
anisotropy was calculated as described in Materials and Methods and plotted
as a function of temperature. Experimental points were fitted with a sigmoid
function. The buffer was 20 mM Mops, at pH 7.5 or pH 4.0.
228 Zoonens et al.
Biophysical Journal 95(1) 225–235
tophan residues with emission at 326 and 347 nm in the
membrane-adsorbed state, and 321 and 339 nm in the in-
serted state (3). In the case of the absorbed peptide, bromine
atoms more efficiently quench the emission of the buried
tryptophan residue (which emits with a maximum at 326 nm),
leading to the significant long-wavelength shift of fluores-
cence (;2 nm at 35C and;8 nm at 15C). However, at low
pH, when the peptide is inserted, the presence of Br2-PCs
induces a slight short-wavelength shift in emission (;1 nm at
both temperatures) and enhanced quenching, which might
suggest an interaction of both tryptophan residues with bro-
mine atoms (with some predominance in the interaction of
the tryptophan residue that emits with a maximum at 339
nm). The enhanced wavelength shift and quenching effi-
ciency of pHLIP adsorbed to a DMPC bilayer surface in the
gel phase in comparison with the liquid phase might suggest
deeper burial of tryptophan residue in the core of the bilayer.
Applying the parallax method (18), the penetration depth
of tryptophan residues of pHLIP adsorbed to the bilayer
surface was calculated from the magnitude of quenching
measured for vesicles containing either (6,7)- or (9,10)Br2-
PCs. Because there is a clear heterogeneity of tryptophan
location in the lipid bilayer, the values obtained from the
parallax method are likely to be associated with the trypto-
phan residues located close to bromine atoms. An important
value needed for the calculation of depth is the distance of
each quencher from the bilayer center. Using x-ray diffrac-
tion, these distances have been determined for a series of Br2-
PCs structured in POPC bilayer-like in the liquid-crystal
phase (24,25), but they need to be known in DMPC bilayers
in both phases, because the bilayer thickness changes with
acyl chain length (26) and with the phase transition. In the last
case, the thickness variations are due to a rigidification of
fatty acyl chains and concern mainly the hydrophobic core
(27). The thickness of DMPC bilayers in the crystal-liquid
phase has been determined to be 35.3 A˚ for the head-head
thickness, i.e., the distance between the phosphate groups,
and 25.4 A˚ for the hydrocarbon core region (28). In the gel
phase, the thickness has been determined to be 40.1 A˚ for the
head-head spacing and 30.3 A˚ for the hydrophobic core re-
gion (29). Based on these values and assuming a uniform
hydrocarbon chain packing across the bilayer, the increments
per CH2 group are equal to 0.907 A˚/CH2 and 1.08 A˚/CH2 in
the liquid-crystal and gel phases, respectively. By using the
same assumptions reported by McIntosh and Holloway (24),
we can make a rough calculation of the distance of each
quencher from the bilayer center. We assume the following:
i), the averaged quencher distances from the bilayer center
are at the averaged positions of the carbon atoms of the fatty
acyl chain to which the bromine atoms are attached; and ii),
the distance between apposing terminal methyl groups is
twice the separation of adjacent methylenes, because the
volume of CH3 is about twice the volume of a CH2 group
(30,31). Consequently, an extra CH2 increment that corre-
sponds to the distance between the terminal methyl group and
the bilayer center is added in the acyl chain length. The re-
spective distances of quenchers from the bilayer center were,
therefore, estimated to be 7.7 A˚ and 9.2 A˚ for (6,7)Br2-PC in
FIGURE 3 Quenched emission spec-
tra of pHLIP by brominated lipids.
pHLIP (0.25 mol %) was mixed with
0.6 mM unlabeled DMPC LUVs or
DMPC LUVs containing 30 mol % (6,7)
Br2-PC. Fluorescence emission spectra of
pHLIP were recorded at 35C (A and C)
and 15C (B and D). The buffer was
20 mM Mops, pH 7.5 (A and B) or pH 4.5
(C and D).
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the liquid-crystal and gel phases, respectively. For (9,10)Br2-
PC, these distances are 5.0 A˚ and 5.9 A˚ in the liquid-crystal
and gel phases, respectively. The depth values zcF of one of
tryptophan residues of pHLIP adsorbed at the membrane
surface were, then, calculated to be 8.0 6 0.1 A˚ at 35C
and 7.6 6 0.2 A˚ at 15C from the center of the bilayer.
These distances correspond to distances of 9.7 A˚ at 35C and
12.5 A˚ at 15C from the positions of phosphate groups in the
membrane.
Measurements of quenching of pHLIP emission by ac-
rylamide also were done. Here, we examine changes of the
acrylamide quenching rate of tryptophan emission from
pHLIP mixed with DMPC or DPPC LUVs at low and high
temperatures and pH values. The slope of the Stern-Volmer
plot gives the Stern-Volmer constant (KSV). This parameter
provides information about the accessibility of tryptophan
residues to the quencher. Acrylamide quenching experiments
were done at pH 7.5 and pH 4.5 with DMPC LUVs at either
35C (liquid-crystal phase) or 15C (gel phase), and with
DPPC LUVs at 35C (gel phase). The averaged Stern-
Volmer constants are reported in Table 1. The value of KSV
obtained at pH 7.5 and in the absence of bilayers, i.e., when
the peptide is present in solution, is close to that expected for
completely water-accessible tryptophan (KSV ¼ 16 M1)
(16). This result supports the idea that the peptide is well
exposed to the solution and does not form clusters. In the
presence of DMPC bilayers in the liquid-crystal phase (at
35C), the KSV value is lower due to the peptide binding to a
bilayer and burial of tryptophan residues into it. The value of
KSV (6.8 M
1), which is the average value for both trypto-
phan residues (buried and exposed) is 46% of the relative
KSV value calculated for the completely exposed tryptophan
residues (100%). This value correlates well with the averaged
value of KSV (48%) obtained from the decomposition anal-
ysis (3). When the pH is titrated to pH 4.5, the KSV constant
found is close to the value expected for completely shielded
tryptophan (KSV ¼ 1.2 M1) (32), because the insertion of
pHLIP in membranes results in burial of both tryptophan
residues. This value correlates well with the averaged value
of the relative KSV constant (15%) obtained as a result of
decomposition analysis. At 15C, the DMPC bilayer is in the
gel phase state and the measuredKSV constant is lower for pH
7.5 (29%) compared to the respective value obtained at 35C,
which is an additional evidence that a part of pHLIP is buried
more deeply in the lipid bilayer in the gel phase. To test
whether the temperature and the phase have an effect on
quenching efficiency, this experiment was carried out at 35C
in DPPC bilayers, which are in a gel phase state (Tm ¼
41.5C) (33). The value of KSV determined at pH 7.5 is close
to that obtained in DMPC at 15C, confirming the absence of
temperature effect on quenching efficiency and proving the
influence of the lipid phase on quenching of pHLIP fluores-
cence. At pH 4.5, the value of KSV is close to that obtained in
DMPC at 35C, suggesting the absence of any measurable
phase effect on quenching efficiency.
Insertion assay
The overlap between the emission spectrum of tryptophan
residues and the excitation spectrum of TMA-DPH enables
FRET from one to the other. This pair of fluorophores was
already used in previous studies and the R0 distance, i.e., the
distance at which 50% of energy transfer is efficient, was
determined to be between 34–39 A˚ (34,35), so we took ad-
vantage of the opportunity to make FRET measurements to
explore pHLIP binding and insertion in lipid bilayers. Fig. 4,
A and B, show emission fluorescence spectra of pHLIP at pH
7.5 and pH 4.3 in the presence of pure POPC bilayers or
POPC bilayers containing TMA-DPH, respectively. When
pHLIP is inserted into the lipid bilayer as a transmembrane
helix, a FRET signal is observed, whereas at neutral pH,
when the peptide is adsorbed on the membrane surface, there
is no significant energy transfer. Even at low pH the energy
transfer is not very efficient considering that R0 is;40 A˚. In a
related study, no energy transfer was observed for melittin
interacting with a lipid bilayer containing TMA-DPH at low
lipid/peptide molar ratio of 60:1 (35). The authors carried out
a very careful analysis of the probability of contacts between
a randomly distributed dye in the bilayer and melittin, and
concluded that the average distance between peptide and dye
is more than 40 A˚. The enhanced efficiency of energy transfer
in case of pHLIP inserted into lipid bilayers indicates closer
contact between one of the tryptophan residues and TMA-
DPH. Our interpretation is that, in the membrane-adsorbed
state of pHLIP, one tryptophan residue is located outside the
membrane (347 nm) and the other is buried in the lipid
bilayer (326 nm), and that they are both too far from TMA-
DPH to produce any significant energy transfer. In the in-
serted form of pHLIP, one tryptophan residue (the exposed
one with emission at 339 nm) is most likely to be located at
level of headgroups and in close contact with TMA-DPH,
which enhances the energy transfer. Further, our view is
supported by the observation of a slight short-wavelength
shift of pHLIP emission after FRET (see Figs. 4 B or 6 A).
Also, the total quantum yield of tryptophan residues (quan-
tum yield of donor) buried inside lipid bilayers is enhanced
and the R0 value, which depends on donor quantum yield, is
expected to increase.
TABLE 1 Stern-Volmer quenching constant KSV of
acrylamide for pHLIP
KSV (M
1)
In buffer
35C
In DMPC
In DPPC
35C35C 15C
pH 7.5 14.8 6.8 4.3 4.0
pH 4.5 – 2.3 – 2.1
pHLIP (0.25 mol %) was mixed with 0.6 mM DMPC LUVs or DPPC
LUVs. The buffer was 20 mM Mops, pH 7.5 or pH 4.5.
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Additional evidence of bilayer perturbations accompanied
by a deeper position of pHLIP adsorbed to the bilayer surface
is given by the changes in the FRET signal with temperature.
For this purpose, pHLIP was mixed with either POPC or
DMPC bilayers containing TMA-DPH at pH 4.3 or pH 7.5
and emission fluorescence spectra were monitored versus
temperature. These two lipid types were chosen because in
the temperature range tested (15C–35C) POPC bilayers are
in the liquid-crystal phase, whereas DMPC bilayers have a
gel-to-liquid crystal phase transition at 23C. To correct for
the temperature effects on fluorescence intensities, the ratios
of emission intensities recorded at 333 and 430 nm at pH 4.3
or recorded at 340 and 430 nm at pH 7.5 are shown in Fig. 5
rather than the absolute intensities. In the presence of POPC
bilayers at pH 4.3, the FRET signal increases linearly with
cooling temperature. The value of the FRET signal is ;30%
stronger at 15C than at 35C probably because of changes in
the degree of hydration of the bilayer. In the presence of
DMPC, the signal is similar to that obtained in POPC at
temperatures above Tm, but a jump is observed below Tm. At
15C, the signal was ;23% higher in DMPC than in POPC
and this difference is associated with rigidification of the
DMPC bilayer due to the phase transition. On the other hand,
in POPC at pH 7.5, the value of the FRET signal is insig-
nificant (Fig. 3 B), so it stays low and stable over the tem-
perature changes. In DMPC, the value of the FRET signal is
close to that obtained in POPC at 35C, whereas it is 53%
higher at 15C. A tentative of interpretation of this obser-
vation is a deeper position of a part of pHLIP in the gel phase
compared to the fluid phase. No variation of the ellipticity
FIGURE 4 pH-dependence of FRET process between pHLIP and TMA-
DPH incorporated in the membrane. pHLIP (0.33 mol %) was mixed with
0.85 mM POPC LUVs (A) or POPC LUVs containing 0.2 mol % TMA-DPH
(B). The samples were excited at 280 nm at 20C. The buffer was 20 mM
Mops, at pH 7.5 or pH 4.3. Light scattering and fluorescence backgrounds of
a blank containing TMA-DPH inserted into LUVs were subtracted from the
spectra.
FIGURE 5 Temperature-dependence of pHLIP fluorescence in the pres-
ence of membranes. pHLIP (0.25 mol %) was mixed with either 0.85 mM
POPC LUVs or DMPC LUVs at pH 4.3 (A) or pH 7.5 (B). Samples were
excited at 280 nm and the emission fluorescence was observed as a function
of temperature. Data are plotted as the ratio of intensities at 333 and 430 nm
for samples at pH 4.3, and at 340 and 430 nm for samples at pH 7.5 to cancel
out the effect of fluorescence quenching due to temperature variations. The
dashed line indicates Tm of phase transition for DMPC at 23C.
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signal was observed by CD after the phase transition, which
means that the variations in the binding mode do not sig-
nificantly alter the secondary structure of the peptide.
Peptide design
Our earlier biophysical studies and those presented here ad-
vance our understanding of the interactions of moderately
polar peptides, like pHLIP, with a lipid bilayer. To broaden
the case, we include the beginnings of an effort to find the key
elements of the amino acid sequence that give pHLIP its
properties. We first studied variants that differ from the wild-
type peptide by the replacement of two aspartate residues
present in the transmembrane domain by either asparagines
(N-pHLIP) or lysines (K-pHLIP). Those peptides were tested
for their ability to insert in membranes (4), and it was shown
that the pH-dependent insertion was affected: N-pHLIP is
present mainly in its helical form and inserts in membranes at
both high and low pHs (but less efficiently than the wild-type
peptide) whereas K-pHLIP is mainly unstructured. Both of
them exhibit aggregation in aqueous solutions. An additional
question that remained unanswered is how the aspartate
residues located outside the transmembrane domain affect the
insertion process. We compared the characteristics of the
wild-type pHLIP with a variant in which its C-terminus is
neutralized by replacing three negatively charged residues
(two aspartates and one glutamate) by three polar, but neutral,
residues (two asparagines and one glutamine). The assay
using FRET, described above, was used for testing the in-
sertion ability of pHLIP and the variant, which were mixed
separately with POPC bilayers containing TMA-DPH at pH
7.4 and pH 4.2 (Fig. 6, A and B). In contrast to the wild-type
peptide, the FRET signal obtained for the variant is not
enhanced after titrating pH 7.4 to 4.2 and no blue-shift is
observed, showing modified efficiency of insertion of the
variant. On the other hand, the CD spectra show that the sec-
ondary structure of pHLIP is strongly affected by the change
of these residues in its C-terminus: at pH 7.8, with or without
a lipid bilayer, the variant presents a mixture of helical and
random structures, whereas the wild-type peptide is com-
pletely unstructured (Fig. 6, C and D). A drop of pH leads to
an increase of helicity. Replacement of the negative residues
FIGURE 6 Insertion ability and secondary structure of wild-type and variant pHLIP peptides. The peptides (0.2 mol %) were separately mixed with 0.85
mM POPC LUVs containing 0.2 mol % TMA-DPH at pH 7.4 or pH 4.2. The emission fluorescence spectra of wild-type (A) and variant (B) peptides, after
excitation at 280 nm, were corrected for light scattering and fluorescence background, and were normalized to the maximal intensity. The buffer was 20 mM
Mops. The peptides (0.8 mol %) were analyzed by CD spectroscopy without or with 0.37 mM DMPC LUVs at 37C, at pH 7.8 and pH 4.3. The CD spectra of
wild-type (C) and variant (D) peptides were corrected for the background contribution, and were smoothed in a window of three points. The buffer was 2 mM
TrisHCl, 5 mM NaCl.
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by neutral ones changes the hydrophobic character of the
peptide (using the octanol/water scale, DG varies from 8.38
to 0.06 kcal.mol1 (36)), which might lead to an aggre-
gation of the peptide in solution and a reduction of its ability
to insert into a lipid bilayer.
DISCUSSION
In this study, we have examined biophysical properties of
the interaction of pHLIP with lipid bilayers. Such properties
are relevant both for improving our understanding of the
insertion of peptides into membranes and for the develop-
ment of therapeutic applications. Before insert, the first re-
quired step is the binding of the peptide to the surface of
membranes, which is the focus of our analysis here. This
study was motivated by previous data showing that pHLIP
induces macroscopic perturbations of intact human RBCs
(4). Accordingly, we investigated the pHLIP binding mode
with the aim of gaining quantitative insights into the bilayer
perturbations and interactions. All the results reported in this
work were obtained on LUVs, a system used widely as a
model for measurements of protein binding to and insertion
into membranes.
From a pharmaceutical or toxicological point of view, any
mechanism of cargo translocation resulting in gross per-
meabilization of the membrane would be unacceptable. The
calcein leakage experiments were, therefore, carried out to
check whether the peptide causes damage to pure phospho-
lipid bilayers and to ensure that the binding of pHLIP does
not lead to membrane permeabilization. The absence of
calcein release from POPC vesicles in the presence of pHLIP
at physiological pH (pH 7.4) confirms the absence of pore
formation compared to melittin. This result is in agreement
with earlier work (3,4). At neutral pH, the interactions of
pHLIP with the biological membranes of human RBCs in-
duce no leakage of hemoglobin while leading to the ap-
pearance of spicules on the surface of the majority of cells.
The formation of spikes when the peptide is bound to the
membrane is interpreted as the consequence of extra area
occupied by pHLIP on the outer leaflet of the lipid bilayer. At
pH 6, i.e., when the peptide is inserted into the membrane, a
greatly reduced number of spikes is seen, which is consistent
with pHLIP insertion across both halves of the bilayer. A
related observation is obtained from lipid fluidity measure-
ments using fluorescence anisotropy of TMA-DPH incor-
porated into the DMPC bilayer. Taking the lipid headgroup
area as 60.6 A˚2 in the liquid-crystal phase (29) and the vesicle
shape as a sphere of 100 nm diameter, the highest peptide
concentration tested (2.0 mol %) corresponds to ;2000
peptides per vesicle, or a low lipid/peptide ratio of 50:1.
Under these conditions, the pHLIP association with the bi-
layer surface gives rise to an increase of lipid microviscosity
and a rise in the Tm of the DMPC phase transition, whereas no
significant perturbation occurs when pHLIP is adsorbed on
the membrane surface at lower concentration or inserted
across the bilayer. Our data are in good agreement with our
isothermal titration calorimetry results, which show two
types of pHLIP interactions with lipid bilayers at low and
high lipid/peptide ratios (5). We found that in the membrane-
bound state at low and high lipid/peptide ratios pHLIP in-
teracts with ;60 and ;120 lipids and that an additional
50–60 and 80–100 lipids are affected (destabilized), respec-
tively, whereas the inserted peptide interacts with only ;22
lipids, which is approximately the first surrounding layer for
a transmembrane helix.
In earlier studies from the Huang laboratory, the interac-
tions of a helical amphiphilic peptide (Alamethicin) with
bilayers were analyzed in detail by x-ray lamellar diffraction
(37). It was shown that the adsorbed peptides on the bilayer
surface lead simultaneously to a disordering of the lipid
chains and to a decrease of the bilayer thickness. The ob-
served effects were ascribed to an increase of the cross sec-
tional area in the polar region that requires accommodation
by the lipids. Similarly, pHLIP increases the area of outer
leaflet of membranes; however, it binds to the surface as an
extended chain, rather than as a helix. Both pHLIP and am-
phiphilic helical peptides can be regarded as anisotropic in-
clusions into a leaflet of the bilayer, inducing membrane
perturbations (38,39). However, the differences in confor-
mation may lead to detailed differences in the interactions,
perhaps including the extent of their insertion into the
headgroups. An indication of this difference is seen in the
deeper surface binding of pHLIP in the gel state and the in-
crease of the transition temperature caused by pHLIP bind-
ing, indicating some stabilization of the gel state. This
unexpected finding may be a worthy subject for further study.
Additional studies of pHLIP binding to the bilayer surface
used fluorescence quenching experiments by either Br2-PCs
or acrylamide. At pH 7.5, the acrylamide quenching Stern-
Volmer constant and the fluorescence quenching efficiency
by Br2-PCs change with the phase transition. In all cases, it
appears that one tryptophan residue is more deeply buried in
the bilayer than the other. This observation correlates well
with our previous fluorescence decomposition analysis that
showed two populations of tryptophan residues (3). The
distance between the buried tryptophan residue of pHLIP and
the center of the bilayer was evaluated by parallax analysis
using (6,7)- and (9,10)Br2-PC as a pair of quenchers (18).
The change of penetration depth after the phase transition
was estimated to be 0.4 A˚ from the bilayer center and 2.8 A˚
from the bilayer phosphate groups given the bilayer thickness
variation. Equilibrium of pHLIP intermediates adsorbed on
the membrane surface could explain the differences observed
in the gel and liquid-crystal phases. The propensity of the
peptide to spontaneously insert into membranes, due to the
presence of its hydrophobic residues, is thermodynamically
opposed by the presence of its charged carboxylates. In this
context, it may be useful to consider that the peptide binding
to the bilayer is highly dynamic. This issue could be inves-
tigated by solution NMR spectroscopy, which can give dy-
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namic information on the conformation of the peptide de-
pending to the timescale of the intermediate equilibrium (40).
Additional results at pH 4.5 indicate that, when the peptide is
inserted across the bilayer, it does not induce significant
perturbation and that variations due to the gel-to-liquid
crystal phase transition are negligible.
We found that energy transfer from the aromatic residues
of pHLIP to the fluorescent probe TMA-DPH anchored in the
polar region of bilayers correlates with the surface binding
and insertion of pHLIP. When the peptide is bound at the
membrane surface (pH 7.5) no significant energy transfer is
observed, whereas when pHLIP is inserted across the bilayer
(pH 4.3) energy transfer is enhanced. The enhancement is
associated most likely with closer contact between one of the
tryptophan residues of pHLIP and TMA-DPH. The FRET
assay done on various lipids at different pHs and tempera-
tures further supported the results of bilayer perturbation at
neutral pH, accompanied by a deeper position of pHLIP on
the bilayer in the gel phase compared to the fluid phase.
The FRET assay was also used to compare pHLIP with a
variant in which the charged Asp and Glu residues located on
the C-terminus of the peptide were changed to the polar but
uncharged side chains Asn and Gln, with the idea that the
peptide insertion might be facilitated if the more polar groups
did not have to be translocated. We observed the formation of
elements of secondary structure for the variant in aqueous
solution and suspect some form of self-association. Based on
the FRET analysis, no significant insertion was seen even if
we noticed by CD a shift toward helix formation at low pH in
the presence of bilayers. Thus, this variation of the amino
acid sequence may not prove useful, except as a caution that
the combination of properties shown by pHLIP may be more
difficult to create than we thought.
The design of sequences with controlled insertion prop-
erties should be aided by knowledge of peptide interactions
with a bilayer. It is important that such a peptide preserves its
ability to be monomeric in aqueous solution as well as when
it is bound to the surface of a bilayer or inserted across it. This
study advances our understanding of pHLIP interaction with
cell membranes and strengthens the view that the mechanism
of pHLIP interaction is different from the mechanism of
amphipathic peptide interaction with a lipid bilayer, where
the insertion involves cooperative oligomerization resulting
in pore formation. The relaxation of lipid distortion has been
proposed as a contributor to the insertion of amphipathic
helices (37,41), but it is important to note that the case of
pHLIP insertion differs in several respects. To consider the
driving forces, one must examine the initial and final equi-
librium states. Amphipathic helices bind at the bilayer sur-
face and distort the lipid as folded helices and attain an
inserted state that has both helix-helix contacts and helix-
lipid contacts, because oligomers form during the process.
On the other hand, pHLIP binds to the surface in an extended,
unfolded form that distorts the lipid, but it is not established
that the distortions are the same as those involved when the
different geometry of a helix is at the surface. The inserted
pHLIP is a single helix, interacting only with lipid, so there is
no need to separate the energies arising from helix-helix in-
teractions from those arising from helix-lipid interactions.
Thus, both the initial and final states of the two systems,
amphipathic helices and pHLIP, differ. The distortion of
lipids induced by pHLIP adsorption is not sufficient to induce
peptide insertion, because pHLIP does not insert as a trans-
membrane helix with an increase of peptide concentration.
Rather, the insertion mechanism of pHLIP is triggered by the
increase of peptide hydrophobicity resulting from the pro-
tonation of negatively charged residues at low pH, which
shifts the equilibrium toward partitioning of the peptide into
the hydrophobic bilayer and the formation of a transmem-
brane helix. At the same time, because the interaction of
pHLIP with the bilayer surface, which is the first step in the
insertion process, distorts the lipids, and because the insertion
across the bilayer relaxes the distortion, we conclude that the
distortion energy of the bilayer might also contribute to the
insertion.
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